Clinical Trial Update: AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients

View source ↗

Summary

A completed clinical trial evaluating real-world monitoring of anti-CMV therapies in hematopoietic stem cell transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections
• Hematopoietic Stem Cell Transplantation

Drugs mentioned

• AntiCMV molecules

Snippet

Sponsor: University Hospital, Limoges | Conditions: Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections | Status: COMPLETED